iShares Biotechnology ETF Newsroom

Morgan Stanley Stays Bullish on AI, Obesity, and Defense Focused Themes

Seeking AlphaAug 28 11:13 ET

This Moderna Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday

BenzingaAug 28 09:39 ET

Exchange-Traded Funds, Equity Futures Edge Lower Pre-Bell Wednesday Ahead of Nvidia Earnings

MT NewswiresAug 28 08:16 ET

Moderna Analyst Ratings

BenzingaAug 28 07:28 ET · Ratings

Eli Lilly Is The Nvidia Of Weight Loss And GLP-1 Space, Says Roundhill Investments CEO, Emphasizes Market Leadership And Growth Potential Of Zepbound Maker

BenzingaAug 28 04:21 ET

Gilead Sciences Trades in the Green for Seventh Straight Session

Seeking AlphaAug 27 16:13 ET

Moderna Unusual Options Activity

BenzingaAug 27 15:15 ET

Decoding Gilead Sciences's Options Activity: What's the Big Picture?

BenzingaAug 27 14:00 ET

Looking Into Vertex Pharmaceuticals's Recent Short Interest

BenzingaAug 27 12:45 ET

Evaluating Regeneron Pharmaceuticals Against Peers In Biotechnology Industry

BenzingaAug 27 11:00 ET

Exchange-Traded Funds Edge Lower, Equity Futures Mixed Pre-Bell Tuesday as Stocks Struggle for Direction

MT NewswiresAug 27 08:31 ET

Ready for Fed Rate Cuts? Biotech's Potential to Watch

Analysts NotebookAug 27 07:33 ET

$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today

BenzingaAug 26 17:00 ET

Sector Update: Health Care Stocks Higher Pre-Bell Monday

MT NewswiresAug 26 09:18 ET

Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Monday as Middle East Tensions Hold Back Markets

MT NewswiresAug 26 08:29 ET

Is the rebound fading? Goldman Sachs: Hedge funds are selling stocks at the fastest pace in more than two years.

In August, 'smart money' is selling global equities at the fastest pace since March 2022, with the most net selling in North America. Hedge funds are skeptical of the sustainability of the stock market rebound, and geopolitical concerns continue to be worrying. The 'fly' of the economic situation may soon hit the glass windshield.

wallstreetcnAug 26 03:22 ET

Regeneron Highlights Scientific Innovation And Leadership In Respiratory Disease Management At ERS 2024, Featuring Dupixent And Itepekimab

BenzingaAug 26 01:48 ET

Eli Lilly, Novo Nordisk to Maintain 'Two Horse Race' in GLP-1 Weight Loss Market

Seeking AlphaAug 25 14:00 ET

Stocks Most Loved and Shunned by Hedge and Mutual Funds

Seeking AlphaAug 25 12:43 ET

Snowflake, JD.com And Temu Parent PDD Are Among Top 8 Large Cap Losers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio?

BenzingaAug 25 12:07 ET